| Millennium and UCB Collaborate on Inflammation |
Abstract
pdf
|
|
Business Review Editor |
|
| Shire and New River: Buying up the Competition |
Abstract
pdf
|
|
Business Review Editor |
|
| Sepracor and ACADIA Forge CNS Alliance |
Abstract
pdf
|
|
Business Review Editor |
|
| Products under Development and the Licensing and Due Diligence Processes |
Abstract
pdf
|
|
Business Review Editor |
|
| Technology Focus: Cell Therapy |
Abstract
pdf
|
|
Business Review Editor |
|
| Chiesi Licenses Second Drug to GB Therapeutics |
Abstract
pdf
|
|
Business Review Editor |
|
| Basilea’s Deal Making Debut |
Abstract
|
|
Business Review Editor |
|
| Valeant Expands Neurology Franchise through Acquisition of Xcel |
Abstract
pdf
|
|
Business Review Editor |
|
| Antisoma Acquires Aptamera |
Abstract
pdf
|
|
Business Review Editor |
|
| Giant Pfizer to Acquire Tiny Angiosyn |
Abstract
pdf
|
|
Business Review Editor |
|
| Schering’s and Novartis’ New Co-Promotion Agreement for PTK/ZK |
Abstract
pdf
|
|
Business Review Editor |
|
